Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received October 4, 2021
- Accepted in final form January 24, 2022
- First Published March 7, 2022.
Author Disclosures
- Barbara A. Hanson, BA (barbara.hanson{at}northwestern.edu),
- Lavanya Visvabharathy, PhD (lavanya.visvabharathy{at}northwestern.edu),
- Sareen T. Ali, BA (sareen.ali{at}northwestern.edu),
- Anthony K. Kang, BS (anthony.kang{at}northwestern.edu),
- Tulsi R. Patel, BA (tulsi.patel{at}northwestern.edu),
- Jeffrey R. Clark, BA (jeffrey.clark{at}northwestern.edu),
- Patrick H. Lim, MS (patrick.lim{at}northwestern.edu),
- Zachary S. Orban, BS (zachary.orban{at}northwestern.edu),
- Soyoon S. Hwang, PhD (shwang{at}quanterix.com),
- Dawn Mattoon, PhD (dmattoon{at}quanterix.com),
- Ayush Batra, MD (ayush.batra{at}nm.org),
- Eric M. Liotta, MD, MS (eric.liotta{at}northwestern.edu) and
- Igor J. Koralnik, MD
- Barbara A. Hanson, BA (barbara.hanson{at}northwestern.edu),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lavanya Visvabharathy, PhD (lavanya.visvabharathy{at}northwestern.edu),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. NIH/NIAMS, T32AR007611, Postdoctoral Fellow, 2020-2022
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sareen T. Ali, BA (sareen.ali{at}northwestern.edu),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Anthony K. Kang, BS (anthony.kang{at}northwestern.edu),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tulsi R. Patel, BA (tulsi.patel{at}northwestern.edu),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jeffrey R. Clark, BA (jeffrey.clark{at}northwestern.edu),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Patrick H. Lim, MS (patrick.lim{at}northwestern.edu),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Zachary S. Orban, BS (zachary.orban{at}northwestern.edu),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Soyoon S. Hwang, PhD (shwang{at}quanterix.com),
NONE
NONE
NONE
NONE
NONE
NONE
Quanterix, Scientist, employee since August 2020
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Dawn Mattoon, PhD (dmattoon{at}quanterix.com),
NONE
NONE
NONE
NONE
NONE
NONE
Quanterix Corporation, Senior Vice President of Clinical Diagnostics , 4 years
NONE
NONE
NONE
NONE
Quanterix Corporation (employee - see above)
NIH RADx Contract, 75N92020C00035, Principle Investigator, Sept. 2020 - present Stock/Stock Options, Medical Equipment & Materials: Quanterix Corporation, 2018 - present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ayush Batra, MD (ayush.batra{at}nm.org),
NONE
NONE
NONE
(1) GeroScience, Associate Editor, 2021 -
NONE
NONE
NONE
NONE
NONE
NONE
NONE
GeNeuro SA, Geneva, Switzerland
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Eric M. Liotta, MD, MS (eric.liotta{at}northwestern.edu) and
NONE
NONE
NONE
(1) Critical Care Explorations, Editorial Board, 2020 (2) Geroscience, Associate Editor, 2020
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) National Institutes of Health, L30NS098427, PI, 5 years
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Igor J. Koralnik, MD
NONE
NONE
NONE
Journal Of NeuroVirology, Editorial Board Member (2008- present)
NONE
UpToDate, Topics on the management of HIV and CNS mass lesions and on PML (2002-present) and neurologic complications of COVID-19 (2020-)
NONE
Received consulting fees from Antisense Therapeutics (2021) Arena Pharmaceuticals (2021), ,Geneuro (2021), Noveome (2021), Oxeia (2021).
NONE
NONE
NONE
NONE
NIH R01 NS 047029, PI, 2004-2021; NIH DP1 DA 048493, PI, 2019-present
NONE
Michael J Fox Foundation (2010-present)
NONE
NONE
NONE
NONE
NONE
NONE
- From the Ken and Ruth Davee Department of Neurology (B.A.H., L.V., S.T.A., A.K.K., T.R.P., J.R.C., P.H.L., Z.S.O., A.B., E.M.L., I.J.K.), Feinberg School of Medicine, Northwestern University; Rush Medical College (B.A.H.), Chicago IL; and Quanterix Corporation (S.S.H., D.M.), Billerica, MA.
- Correspondence
Dr. Koralnik igor.koralnik{at}northwestern.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
- No related articles found.